Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

BACKGROUND/AIMS: The approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). METHODS: We assessed the sustained virological response (SVR) of SOF-based regimens in a real-world single-center setting for the treatment of chronic HC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut Liver
Autors principals: Shin, Hyun Phil, Burman, Blaire, Kozarek, Richard A., Zeigler, Amy, Wang, Chia, Lee, Houghton, Zehr, Troy, Edwards, Alicia M., Siddique, Asma
Format: Artigo
Idioma:Inglês
Publicat: Editorial Office of Gut and Liver 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593334/
https://ncbi.nlm.nih.gov/pubmed/28651301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16447
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars